Results 91 to 100 of about 30,368 (178)

Molecular pathways driving clarithromycin benefit in community-acquired pneumonia: analysis of the ACCESS randomised trial. [PDF]

EBioMedicine
Stylianakis E, Kakavoulis N, Foutadakis S, Koufargyris P, Niotis G, Akinosoglou K, Iliopoulou K, Kotsaki A, Chatzopoulos M, Skorda L, Tzavara V, Chrysos G, Gerakari S, Katsaounou P, Kontopoulou T, Dalekos GN, Kumar V, Netea MG, Torres A, Niederman M, Giamarellos-Bourboulis EJ.   +20 more
europepmc   +1 more source

Economic Evaluation of Empirical and Tailored Helicobacter pylori Eradication Strategies Including Second-Line Therapy. [PDF]

Korean J Helicobacter Up Gastrointest Res
Kim JS, Jeong Y, Lee H, Kim BW.
europepmc   +1 more source

Ten-Year Trends in First- and Second-Line <i>Helicobacter pylori</i> Eradication Rates at a Regional Hospital in Japan. [PDF]

Juntendo Med J
Shimada Y, Hojo M, Nago H, Yamaguchi M, Kato Y, Om R, Terai Y, Kita Y, Ikeda Y, Sato S, Murata A, Sato S, Nagahara A, Genda T.   +13 more
europepmc   +1 more source

Multiplex fluorescent PCR-based detection of Helicobacter pylori nucleic acid and antibiotic resistance genes in clinical stool samples: a performance evaluation from Gansu Province, China. [PDF]

BMC Infect Dis
Dong Y, Yang J, Xie B, Wang Y, Chen X, Zhang D.   +5 more
europepmc   +1 more source

Development of Keystone Macrolide Antibiotics via Selective Oxidation. [PDF]

ACS Cent Sci
Moore E, Fraley AE.
europepmc   +1 more source

Clarithromycin crystalluria

Journal of Laboratory Medicine
Zhao Weihua, Zhang Tongyan
doaj   +1 more source

Evaluation of the post-antibiotic effect against <i>Mycobacterium abscessus</i> by a bioluminescence method. [PDF]

Microbiol Spectr
Bonnet I, Bryk R.
europepmc   +1 more source

High Levels of <i>Helicobacter pylori</i> Antimicrobial Resistance in Ireland-A Multicentre Study. [PDF]

Microorganisms
Butler TJ, Molloy S, Douglas A, Brennan D, FitzGerald R, Costigan C, Parihar V, Van Der Merwe K, Semenov S, Tighe D, Hough S, Kevans D, O'Morain C, McNamara D, Smith SM.   +14 more
europepmc   +1 more source

Efficacy and Safety of Fexuprazan-Based Modified High-Dose Dual Therapy for Helicobacter pylori Eradication: A Randomized Clinical Trial. [PDF]

Helicobacter
Ahn JY, Shim KN, Park JH, Kim SG, Kim JH, Moon JS, Youn YH, Kim JJ.   +7 more
europepmc   +1 more source

Assessment of treatment effectiveness, follow-up results, and recurrence patterns in children with <i>Helicobacter pylori</i> infection. [PDF]

Front Pediatr
Luo M, Wei D, Jin L, Wei Y.
europepmc   +1 more source